Zentiva Competitors and Similar CompaniesClear all
Swedish Orphan Biovitrum's competitors and similar companies include Ipsen.
 Swedish Orphan Biovitrum Swedish Orphan Biovitrum (Sobi) is an integrated biotechnology company that researches, develops, manufactures, and sells treatments in the areas of hematology, immunology, and specialty care. | ||
Founding Date | Founding Date 2010 | Founding Date 1929 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Boulogne-Billancourt, FR HQ Algiers, DZ South Yarra, AU Wien, AT Merelbeke, BE São Paulo, BR Mississauga, CA see more | |
Employees | Employees 1,895 | Employees 5,358 |
Valuation ($) | Valuation ($) 11.1 b | Valuation ($) 10.2 b |
Financial | ||
Revenue (est.) | Revenue (est.) kr28.2b (FY, 2025) | Revenue (est.) €3.7b (FY, 2025) |
Cost of goods | Cost of goods kr6.2b (FY, 2025) | Cost of goods €659.1m (FY, 2025) |
Gross profit | Gross profit kr22b (FY, 2025) | Gross profit €3.3b (FY, 2025) |
Net income | Net income kr476m (FY, 2025) | Net income €445.1m (FY, 2025) |
For sources of this data, please see the company profile